Aspirin induced asthma (AIA) is more common in women than in men. The first symptoms of the disease are often a viral respiratory infection which is followed by a prolonged and perennial rhinitis.
members were atopic or had moderate eosinophilia, the aspirin challenge was negative in all.
Eosinophilic inflammation of airways in AIA Signs of persistent inflammation of the bronchi in patients with AIA are characterised by eosinophilic infiltration, desquamation of epithelia, increased cytokine production, and expression of adhesion molecules. 7 Bronchial biopsy specimens reveal a fourfold increase in eosinophils in patients with AIA compared with aspirin tolerant asthmatic subjects. 8 Mast cell counts are variable, probably reflecting activation of this cell population. Increased eosinophilia in the bronchi is accompanied by increased expression of interleukin (IL)-5, a cytokine directing maturation, activation, recruitment, and prevention of eosinophil apoptosis. Since the frequency of atopy is similar in patients with AIA and in aspirin tolerant asthmatics, 9 persistent eosinophilic inflammation has to result from another mechanism. A chronic viral infection and/or autoimmunisation are likely events preceding the onset of AIA. 10 In fact, many patients with AIA have a low titre of anti-DNA antibodies, enhanced IgG synthesis, and associated HLA antigens.
Infiltrating eosinophils are a site of cysteinyl leukotriene (cys-LT) synthesis, as demonstrated by immunostaining of LTC 4 synthase. The overexpression of LTC 4 synthase in bronchial biopsy specimens of patients with AIA correlates with aspirin sensitivity and is several times higher than in aspirin tolerant asthmatic subjects.
8
Lipid mediators of asthma and aspirin sensitivity Despite numerous attempts, no immune system mediated hypersensitivity to aspirin has been found in patients with AIA. In addition, cross sensitivity to other non-steroidal antiinflammatory drugs (NSAIDs), represented by a variety of chemical compounds, would suggest that any immune response dependent mechanism is improbable. Cyclo-oxygenase (COX) is a common target for the action of NSAIDs. Careful comparison of inhibitory spectra of several NSAIDs suggests that inhibition of COX-1 rather than COX-2 triggers bronchoconstriction in sensitive patients.
11
Measurements of COX metabolites in the body fluids, especially in bronchoalveolar lavage fluid, demonstrate diminished biosynthesis of prostaglandin E 2 (PGE 2 ) in patients with AIA. Administration of aspirin further suppresses PGE 2 production, but this is not reflected by inhibition of the synthesis of other prostanoids as can be seen on COX inhibition in aspirin tolerant asthmatics. 12 PGE 2 is a probable trigger for asthmatic attacks in AIA; inhibition of its synthesis removes PGE 2 mediated restraints on inflammatory cells. This prostaglandin, in addition to its anti-inflammatory properties, can relax smooth muscles. Genetic screening of COX genes has not revealed any alterations to explain this phenomenon. PGE 2 synthase, which is an inducible and glutathione dependent enzyme, has been newly cloned 13 but no studies in patients with AIA are yet available.
LTC 4 seems to be the most important bronchoconstrictor mediator of asthma in aspirin sensitive disease.
14 Urinary excretion of LTE 4 is increased by 2-10 times in aspirin sensitive asthmatics compared with aspirin tolerant patients. During inhalatory aspirin challenge, a further transient increase in LTE 4 excretion in the urine is observed in patients with AIA. 15 Cys-LTs can be released into the nasal cavity and bronchi after local deposition of aspirin. 12 16 The first step in the biosynthesis of cys-LTs is accomplished by 5-lipoxygenase (5-LO) and 5-LO associated protein (FLAP). Expression of 5-LO is modulated by a genetic variation in the SP1 transcription factor binding motif of the 5-LO gene, although no association between allelic variants of 5-LO gene promoter and AIA have been found. 17 Immunostaining of bronchial biopsy specimens for 5-LO and FLAP have not revealed any diVerence with regard to aspirin sensitivity. 8 Thus, only LTC 4 synthase, a terminal enzyme for cys-LT production, is the pathway constituent distinguishing patients with AIA. Overexpression of LTC 4 synthase could result from an intense enzyme induction in cells infiltrating bronchi of patients with AIA, but the possibility of a genetic mechanism facilitating the LTC 4 synthase gene transcription has been tested. 4 synthase controls biosynthesis of leukotrienes LTC 4 synthase is expressed in eosinophils, basophils, and macrophages. In some other cells such as the epithelia, endothelia, and platelets the enzyme is an orphan because of lack of 5-LO expression. In these cells production of LTC 4 synthase depends on external sources of LTA 4 . The LTC 4 synthase gene has been cloned and its sequence, molecular organisation, and functional analysis have been described. 18 A common allelic variant of the LTC 4 synthase gene distinguished by the transversion of adenine (A) to cytosine (C), 444 bases upstream from the translation start, was found during screening of the 5' region of the gene. 19 In a population of asthmatic patients with more than 60 individuals in each group, the allele C frequency was 39% in patients with AIA but 26% in aspirin tolerant asthmatics and 25% in healthy controls. 20 Semiquantitative studies of LTC 4 synthase transcripts in peripheral blood eosinophils (fig 1) revealed increased numbers of mRNA copies in patients with AIA. This increase correlated with the presence of the allelic C variant of LTC 4 synthase. 21 By functional studies, vectors carrying either the C or A allele of the 5' end of the LTC 4 synthase gene and expressed in eukaryotic cell lines showed that allele C produced a moderate (25%) enhancement of the reporter gene transcription. 22 A diVerence in binding of transcription factors created by the transversion has been analysed by oligonucleotide shift assay. Incubations of double strand oligonucleotides encompassing the transversion with nuclear extracts had a three times higher aYnity of transcription factor AP2 for allele C. In addition, because of the overlap of the DNA motifs, allele C can interact with another transcription factor (fig 2) , namely H4TF-2. An interaction of cytokine induced AP2 with a cell cycle dependent H4TF-2 is probably the cause of the higher expression of LTC 4 Hours LTE 4 (ng/mg creatinine)
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